| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 146 |
| 1 | PREDNISONE | 140 |
| 2 | TACROLIMUS | 96 |
| 3 | PREDNISOLONE | 88 |
| 4 | PREDNISOLONE ORAL | 88 |
| 5 | PREDNISOLONE ORAL SOLUTION | 88 |
| 6 | OMEPRAZOLE MAGNESIUM | 85 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 81 |
| 8 | TACROLIMUS OINTMENT 0.1% | 81 |
| 9 | FUROSEMIDE | 79 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| 1 | CASPOFUNGIN ACETATE | 17 | 0.0107 |
| 2 | DARIFENACIN HYDROBROMIDE | 8 | 0.0092 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 55 | 0.0066 |
| 4 | MILTEFOSINE | 2 | 0.0052 |
| 5 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 6 | CEFTOLOZANE AND TAZOBACTAM | 4 | 0.0041 |
| 7 | DIMETICONE | 1 | 0.0035 |
| 8 | RIFABUTIN | 9 | 0.0033 |
| 9 | CEFIDEROCOL SULFATE TOSYLATE | 1 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 343 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 153 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 135 |
| 3 | Proton Pump Inhibitor [EPC] | 110 |
| 4 | Benzodiazepine [EPC] | 100 |
| 5 | Loop Diuretic [EPC] | 90 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 77 |
| 7 | Insulin Analog [EPC] | 70 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 68 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 67 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 3 | 0.0036 |
| 2 | Rifamycin Antimycobacterial [EPC] | 9 | 0.0026 |
| 3 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 4 | Antifibrinolytic Agent [EPC] | 16 | 0.0016 |
| 5 | Penem Antibacterial [EPC] | 53 | 0.0015 |
| 6 | Humanized Monoclonal Antibody Fragment [EPC] | 2 | 0.0014 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 27 | 0.0012 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 9 | Tetracycline-class Antibacterial [EPC] | 9 | 0.0011 |